Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR)

详细信息    查看全文

• 作者：Philippe Chevalier ; Alain Leizorovicz ; Pablo Maureira ; Jean-Pierre Carteaux ; Hervé ; Corbineau ; Thierry Caus ; Brigitte DeBreyne ; Philippe Mabot ; Christian Dechillou ; Jean-Claude Deharo ; Serge Barry
• 关键词：Atrial fibrillation ; Mitral valve disease ; Radiofrequency ablation
• 刊名：Archives of Cardiovascular Diseases
• 出版年：2009
• 出版时间：November 2009
• 年：2009
• 卷：102
• 期：11
• 页码：769-775
• 全文大小：342 K

文摘

Summary

Background

Randomized studies evaluating left atrial radiofrequency ablation (RFA) in patients with persistent atrial fibrillation undergoing mitral valve surgery are scarce and monocentric.

Aim

To evaluate the efficacy of left atrial RFA concomitant with mitral valve surgery to restore and maintain sinus rhythm.

Methods

The SAFIR is a multicentre, double-blinded, centrally randomized study involving four university hospitals. Between December 2002 and September 2005, 43 patients with mitral valve disease and long-standing, persistent atrial fibrillation (duration > 6 months) were included. We compared valvular surgery alone (n = 22) or with left atrial RFA (n = 21). The main endpoint was sinus rhythm at 12 months without recurrence of arrhythmia during follow-up. Secondary endpoints were surgical adverse events, atrial fibrillation relapses, stroke and echocardiographic measurements after three and 12 months’ follow-up. Analyses of the efficacy criteria were performed on an intention-to-treat basis.

Results

The primary endpoint occurred significantly more often in the RFA group than in the control group (respectively, 12/21 patients [57 % ] vs 1/22 patients [4 % ]; p = 0.004). There were more patients with sinus rhythm in the RFA group than in the control group at discharge (72.7 % vs 4.8 % ; p < 0.005), 3-month follow-up (85.7 % vs 23.8 % ; p < 0.01) and 12-month follow-up (95.2 % vs 33.3 % ; p < 0.005). The patients in the RFA group had similar rates of postoperative complications and stroke during follow-up as those in the control group.

Conclusions

This multicentre study suggests that left atrial RFA is effective and safe in patients with chronic atrial fibrillation and mitral valve disease.